世界のアフェレーシス市場（治療＆ドナーアフェレーシス/血液成分採取）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 BLOOD SHORTAGE & BLOOD SAFETY TO INCREASE THE DEMAND FOR APHERESIS BLOOD
3.3.1.2 ADVANTAGE OF APHERESIS COLLECTION OVER WHOLE BLOOD COLLECTION TO BOOST THE GROWTH
3.3.1.3 INCREASING DEMAND FOR PLASMA DERIVED PRODUCTS TO SPUR THE APHERESIS MARKET
3.3.1.4 INCREASE IN AGING POPULATION DEMANDS GROWTH OF APHERESIS
3.3.2 RESTRAINTS
3.3.2.1 LACK OF AWARENESS & CHALLENGES IN DONOR RECRUITMENT TO RESTRICT THE GROWTH OF APHERESIS
3.3.2.2 HIGH COST OF APHERESIS PROCEDURES TO HINDER THE ACCEPTABILITY
3.3.3 OPPORTUNITIES
3.3.3.1 EXTENDING REACH OF APHERESIS
3.3.3.2 UNTAPPED PEDIATRIC SEGMENT CAN SOON GAIN IMPORTANCE IN APHERESIS
3.4 MARKET SHARE ANALYSIS
3.5 END-USER ANALYSIS

4 GLOBAL MARKET, BY PROCEDURE
4.1 INTRODUCTION
4.2 AUTOMATED/APHERESIS BLOOD COLLECTION (DONOR APHERESIS)
4.3 THERAPEUTIC APHERESIS
4.3.1 NEUROLOGIC DISORDERS
4.3.2 BLOOD DISORDERS
4.3.3 RENAL DISORDERS
4.3.4 METABOLIC DISORDERS
4.3.5 OTHER DISORDERS

5 GLOBAL MARKET, BY PRODUCT TYPE
5.1 INTRODUCTION
5.2 DEVICES
5.3 DISPOSABLES

6 GLOBAL MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 CENTRIFUGATION
6.2.1 DRIVER & RESTRAINT
6.2.1.1 ADVANTAGES OFFERED BY CENTRIFUGATION TECHNOLOGY OVER MEMBRANE SEPARATION
6.2.1.2 CENTRIFUGATION APHERESIS PROCESS IS TIME-CONSUMING
6.3 MEMBRANE SEPARATION

7 GLOBAL MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 PLASMAPHERESIS
7.2.1 DRIVERS
7.2.1.1 HUGE DEMAND FOR PLASMA FROM BIOPHARMACEUTICAL COMPANIES
7.2.1.2 NEW APPLICATIONS AND OPPORTUNITIES IN DEVELOPING COUNTRIES
7.3 PLATELETPHERESIS
7.4 ERYTHROCYTAPHERESIS
7.5 LEUKAPHERESIS
7.6 OTHERS

8 GEOGRAPHIC ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.3 EUROPE
8.4 ASIA
8.5 ROW (REST OF THE WORLD)

9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MERGERS & ACQUISITIONS
9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 127
9.4 PRODUCTS LAUNCH
9.5 EXPANSIONS
9.6 OTHER DEVELOPMENTS
9.7 APPROVALS

10 COMPANY PROFILES(OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)*
10.1 ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF
10.2 B. BRAUN MELSUNGEN AG
10.3 CERUS CORPORATION
10.4 FENWAL, INC.
10.5 FRESENIUS MEDICAL CARE AG & CO. KGAA
10.6 HAEMONETICS CORPORATION
10.7 HEMACARE CORPORATION
10.8 KANEKA CORPORATION
10.9 KAWASUMI LABORATORIES, INC.
10.1 MEDICA S.P.A
10.11 NIKKISO CO., LTD.
10.12 TERUMO BCT, INC.
10.13 THERAKOS, INC.
*DETAILS ON FINANCIALS, PRODUCT & SERVICES, STRATEGY, & DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.